| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/03/1999 | EP0898965A2 Use of tetrahydrofolates for modulating the homocysteine level |
| 03/03/1999 | EP0898964A1 Method for treating heart failure |
| 03/03/1999 | EP0898963A2 Congestive heart failure treatment |
| 03/03/1999 | EP0898559A2 Cytoprotective compounds |
| 03/03/1999 | EP0754190B1 An equilin double bond isomer from the acid isomerization of equilin |
| 03/03/1999 | EP0745080B1 Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 03/03/1999 | EP0731791B1 benzenesulfonylimine derivatives as inhibitors of il-1 action |
| 03/03/1999 | EP0724570B1 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 03/03/1999 | CN1209331A Chinese medicine for treating deep phlebothrombosis |
| 03/03/1999 | CN1209316A Combined medicinal preparation of sodium/hydrogen exchange-pump inhibitor and medicine for treatment of angiocardiopathy |
| 03/03/1999 | CA2242313A1 Signal recognition particle polypeptides and polynucleotides |
| 03/02/1999 | US5877342 Skin disorders; respiratory system disorders; cardiovascular disorders |
| 03/02/1999 | US5877317 Heterocyclic compounds for the treatment of CNS and cardiovascular disorders |
| 03/02/1999 | US5877313 Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP |
| 03/02/1999 | US5877302 Compacted nucleic acids and their delivery to cells |
| 03/02/1999 | US5877219 Non-steroidal ligands for the estrogen receptor |
| 03/02/1999 | US5877203 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
| 03/02/1999 | US5877193 Use of N-(4-aryl-thiazol-2-yl)-sulfonamides |
| 03/02/1999 | US5877176 Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis |
| 03/02/1999 | US5877169 Methods of treatment of ischemic damage |
| 03/02/1999 | US5877022 Ribozymes targeted to APO(a) RNA |
| 03/02/1999 | US5877016 Human trk receptors and neurotrophic factor inhibitors |
| 03/02/1999 | US5876971 Amino acid sequence of protein isolated from insects which suck the blood of mammals; anticoagulants; treatment of thromboses or unstable angina or arteriosclerosis; prevention of reblockage of vessels after angioplasty |
| 03/02/1999 | US5876968 Mixture of disulfide bonded dimer of al-milano, lipid lowering agent, and carrier; drug for treatment of athlerosclerosis and cardiovascular disease; prodrug for monomer; prevention of thrombosis |
| 03/02/1999 | US5876693 Hydroxyalkyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals |
| 03/02/1999 | CA2242315A1 Mecb |
| 03/02/1999 | CA2242252A1 Dexb |
| 03/02/1999 | CA2241417A1 Novel ffh |
| 03/02/1999 | CA2175458C Novel benzenesulfonylimine derivatives as inhibitors of il-1 action |
| 03/01/1999 | CA2242311A1 Novel compounds |
| 02/28/1999 | CA2241427A1 Novel pyrr homolog |
| 02/27/1999 | CA2245776A1 Pharmaceutical combination preparation of an inhibitor of the sodium/hydrogen exchanger and a medicament for the treatment of cardiovascular diseases |
| 02/26/1999 | CA2241431A1 Novel spoiiie |
| 02/25/1999 | WO1999009157A1 POLYPEPTIDE HAVING A GTPase REGULATOR ACTIVITY, NUCLEIC ACIDS CODING THEREFOR AND THEIR USE IN DIAGNOSTICS AND THERAPY |
| 02/25/1999 | WO1999009146A1 Human serum inducible kinase (snk) |
| 02/25/1999 | WO1999009054A2 Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders |
| 02/25/1999 | WO1999009049A1 Hypoxia-regulated genes |
| 02/25/1999 | WO1999009046A1 Hypoxia-regulated genes |
| 02/25/1999 | WO1999009030A1 Naphthyridinones for inhibiting protein tyrosine kinase and cell cycle kinase mediated cellular proliferation |
| 02/25/1999 | WO1999009027A1 (hetero)aryl-sulfonamide derivatives, their preparation and their use as factor xa inhibitors |
| 02/25/1999 | WO1999009025A2 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives interacting with the dopamine d4 receptor |
| 02/25/1999 | WO1999009006A1 SYNTHESIS OF CLASTO-LACTACYSTIN β-LACTONE AND ANALOGS THEREOF |
| 02/25/1999 | WO1999009003A1 3-aryl-succinamido-hydroxamic acids, methods for producing said acids and medicaments containing the same |
| 02/25/1999 | WO1999008697A1 Treatment of congestive heart failure with growth hormone secretagogues |
| 02/25/1999 | WO1999008510A1 Atrial natriuretic factor mutants and ischemic stroke |
| 02/25/1999 | WO1998053050A3 Short peptides which selectively modulate the activity of serine/threonine kinases |
| 02/25/1999 | DE19736772A1 New guanidino-substituted bi:cyclic peptide compounds |
| 02/25/1999 | CA2301862A1 Atrial natriuretic factor mutants and ischemic stroke |
| 02/25/1999 | CA2301054A1 Synthesis of clasto-lactacystin .beta.-lactone and analogs thereof |
| 02/25/1999 | CA2300912A1 3-aryl-succinamido-hydroxamic acids, methods for producing said acids and medicaments containing the same |
| 02/25/1999 | CA2300848A1 Treatment of congestive heart failure with growth hormone secretagogues |
| 02/25/1999 | CA2300805A1 Polypeptide having a gtpase regulator activity, nucleic acids coding therefor and their use in diagnostics and therapy |
| 02/25/1999 | CA2298866A1 Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders |
| 02/25/1999 | CA2241403A1 Murb |
| 02/24/1999 | EP0897986A2 Aspartic proteinase 5 (ASP5) |
| 02/24/1999 | EP0897980A2 CXCR4B: A human splice variant of CXCR4 chemokine receptor |
| 02/24/1999 | EP0897979A2 Human sdr2 cdna clone |
| 02/24/1999 | EP0897912A1 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 02/24/1999 | EP0897908A1 3-Aryl-succinamido-hydroxamic acids, process for their preparation and medicaments containing them |
| 02/24/1999 | EP0897390A1 Human tumor necrosis factor delta and epsilon |
| 02/24/1999 | EP0897303A1 Inhibitors of farnesyl-protein transferase |
| 02/24/1999 | EP0703904B1 Pyrimidine cyanoguanidines as k-channel blockers |
| 02/24/1999 | EP0673375B1 Fused benzo compounds |
| 02/24/1999 | CN1209139A Prodrugs of thrombin inhibitors |
| 02/24/1999 | CN1209132A Macrocyclic compounds made from suboxide units |
| 02/24/1999 | CN1209066A Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restemosis |
| 02/24/1999 | CN1209063A Vitronection receptor antagonists |
| 02/24/1999 | CN1209060A Vitronectin receptor antagonists |
| 02/24/1999 | CN1208648A Chinese herb medicine allicin health-care liquid |
| 02/24/1999 | CN1208629A Health-care tea for promoting blood circulation and lowering blood pressure and method for preparing same |
| 02/23/1999 | US5874585 Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase |
| 02/23/1999 | US5874472 Aminoacid derivatives as no synthase inhibitors |
| 02/23/1999 | US5874461 Use of Nebivolol as an anti-atherogenic |
| 02/23/1999 | US5874445 (+) -α- (2,3-dimethoxyphenyl)-1-(2-(4-fluorephenyl) ethyl)-4-piepridinemethanol |
| 02/23/1999 | US5874433 Treating prophylaxis or hypotension induced by cytokine therapy or exposure to bacterial endotoxin by administering a nitric oxide synthase inhibitor |
| 02/23/1999 | US5874426 Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| 02/23/1999 | US5874420 Process for regulating vagal tone |
| 02/23/1999 | US5874273 Nucleic acids for encoding genes and amino acid sequences and hybridization and nucleotide sequences |
| 02/23/1999 | US5874252 Splicing variant of the Epstein-Barr virus-induced G-protein coupled receptor |
| 02/23/1999 | US5874245 Human G-protein coupled receptor (HIBCD07) |
| 02/23/1999 | US5874224 Growth factor receptor binding protein |
| 02/23/1999 | US5874080 Administering a therapeutic polypeptide antiallergens to inhabit elastase release by neutrophils |
| 02/23/1999 | US5873811 Method for inhibiting restonosis at a vessel wall region |
| 02/23/1999 | CA2011143C Pyridinecarboxylic acid amide derivatives and pharmaceutical compositions comprising same |
| 02/21/1999 | CA2241428A1 Asp5 |
| 02/20/1999 | CA2241429A1 Cxcr4b: a human splice variant of cxcr4 chemokine receptor |
| 02/19/1999 | CA2245095A1 Method for treating heart failure |
| 02/19/1999 | CA2241433A1 Novel compounds |
| 02/18/1999 | WO1999007855A1 Neutral sphingomyelinase |
| 02/18/1999 | WO1999007827A1 Use of lactobacillus for reduction of the fibrinogen level in blood |
| 02/18/1999 | WO1999007737A2 Lsr receptor, cloning and uses |
| 02/18/1999 | WO1999007736A2 Lipoprotein-regulating medicaments |
| 02/18/1999 | WO1999007732A1 SELECTIVE FACTOR Xa INHIBITORS |
| 02/18/1999 | WO1999007729A2 Peptides having potassium channel opener activity |
| 02/18/1999 | WO1999007703A1 4-AMINOPYRROLE(3,2-d) PYRIMIDINES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS |
| 02/18/1999 | WO1999007700A1 Bicyclic compounds as ligands for 5-ht1 receptors |
| 02/18/1999 | WO1999007681A1 2-acylaminopropanamines as tachykinin receptor antagonists |
| 02/18/1999 | WO1999007678A1 Indole derivatives as mcp-1 receptor antagonists |
| 02/18/1999 | WO1999007670A1 Anthranilic acid analogs |
| 02/18/1999 | WO1999007669A1 Anthranilic acid analogs |